Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hufvudstaden welcomes ASKET to Bibliotekstan

Swedish brand ASKET is to open in one of Hufvudstaden’s properties at Norrmalmstorg in Bibliotekstan, central Stockholm, in the spring of 2021. The store has an area of 120sqm.Asket is a sustainable menswear brand on a mission to reduce the overconsumption of clothing. The company’s business concept is to abandon seasonal collections and instead build a permanent collection of mindfully produced, traceable, and timeless quality garments. Asket was established in 2015 by August Bard Bringéus and Jakob Dworsky. “It’s extremely gratifying that ASKET has chosen Bibliotekstan as the location

Lundin Mining Announces Resumption of Full Production Rates at Chapada Mine

Toronto, ON, December 21, 2020 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) announced today that a return to full production rates has been achieved at the Chapada mine in Brazil.   Return to full processing capacity was achieved following the installation of the remaining repaired motor on the ball mill on December 20, 2020. The processing plant achieved approximately 35% of nameplate capacity while operating only the SAG mill and throughput further improved mid-November with the installation of a single motor on the ball mill.

Positive results show that C21 can become an important complement to COVID-19 vaccines

Gothenburg, December 21, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders, today reports an expanded data analysis to follow up the encouraging top line data from the ATTRACT study reported on December 8, 2020. The data show restoration of lung function in COVID-19 with the company’s oral lead candidate drug C21, suggesting that C21 can become an important complement to vaccines to combat the COVID-19 pandemic. A webcast presentation will be held today at 15:00 CET (9:00 am EST).With COVID-19 increasing

Outokumpu extends the maturity of its syndicated revolving credit facility with key lenders

Outokumpu OyjPress releaseDecember 21, 2020 at 9.00 am EETOutokumpu extends the maturity of its syndicated revolving credit facility with key lenders Outokumpu has agreed an amendment of the terms and conditions of its syndicated Revolving Credit Facility agreement allowing for two consecutive yearly extension requests (1+1) of the maturity dates until the end of May 2024. Following this amendment, Outokumpu has requested a one-year maturity extension until the end of May 2023 and has received confirmation from the facility agent that the key lenders have agreed to the request. Out

Updated financial outlook for 2020 and trading update

Trading update AdColony Since we reported our 3Q20 numbers on October 27, we have seen accelerating revenue growth in November, and so far in December which are significantly above our expectations. The above-expected results come from the Brand part of AdColony which contributes around 80% of revenue and is across all geographies, including APAC, EMEA and the US and fueled in particular by our programmatic business. Gross margins quarter to date are slightly above expectations and what we saw in 3Q20. Trading update Bemobi Due to the ongoing IPO process which had launched when we

First dosing of nanoformed drug successfully accomplished

Press Release Nanoform Finland Plc December 21[st], 2020 at 09.00 a.m. Finnish time First dosing of nanoformed drug successfully accomplished Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced that the first full cohort of twelve healthy volunteers has during the weekend at Quotient Sciences’ facilities in Nottingham, UK, been successfully dosed in the first ever phase 1 human trial of a nanoformed drug candidate using Nanoform’s proprietary CESS[®] technology. Results are expected before the end of Q2/

Veidekke ASA: Enters into sustainability-linked bank financing

Veidekke ASA has entered into an agreement with SEB for a NOK 750 million credit facility. The agreement is a sustainability-linked revolving credit facility related to reduction of greenhouse gas emissions and zero serious injuries.“Veidekke has set clear climate goals, which entail a 50% reduction in CO\2\ emissions by 2030. Safety at work is also absolutely crucial for Veidekke, and our goal is zero serious injuries. These are key goals for Veidekke's operations, and we are therefore pleased to be able to incorporate them into our financing. SEB has been a good and competent supporter in

Peab has agreed to sell four tenancy projects for a total of SEK 824 million

Peab has signed a contract to sell four tenancy projects for a total of SEK 824 million all of which will be on Peab’s own balance sheet under construction and then finished and turned over in 2023.Peab has signed a contract to sell four tenancy projects with a total of 312 apartments for a total value of SEK 824 million. The four projects consist of 84 apartments in Botkyrka, 79 apartments in Västerås, 108 apartments in Eskilstuna and 41 apartments in Trollhättan. The project Flottiljen in Botkyrka is sold to Niam, the project Poseidon in Västerås and Fristaden in Eskilstuna are sold to

Veidekke ASA: Signs new bank financing agreements adapted to a streamlined construction company

Veidekke ASA has entered into agreements to refinance existing bank loans in DNB and SEB. The agreements are part of the adjustment of the group's capital structure and financing conditions following the divestment of Veidekke Property Development in early autumn.Veidekke has restructured the current overdraft facility with the group’s main bank DNB to a NOK 1,750 million rolling 364-day facility. With SEB, Veidekke has renegotiated a NOK 750 million credit facility with a three-year term and options for two subsequent one-year extensions. The terms of the credit facility are

Skanska builds rental apartments in Espoo, Finland, for EUR 39M, about SEK 395M

Skanska has signed a contract with Citycon Oyj to build rental apartments in Espoo, Finland. The contract is worth EUR 39M, about SEK 395M, which will be included in the Nordic order bookings for the fourth quarter 2020.The project encompasses 275 apartments in four separate buildings, totaling approximately 12,800 square meters. The buildings will be heated with geothermal energy and solar panels will help generate some of the electricity used by the property. The buildings will be on the same site with Lippulaiva shopping center which is also currently being built by Skanska. Skanska has

Aker Solutions Wins Bid for Ormen Lange Onshore Scope

December 21, 2020 - Aker Solutions has been awarded a letter of intent from Norske Shell for the Ormen Lange Phase 3 (OLP3) onshore project. The scope is to integrate the wet gas subsea compression system with the Nyhamna onshore gas plant in Norway. Subsea compression will enable increased recovery from the Shell-operated Ormen Lange field. Aker Solutions’ scope includes a 500-metric-ton module which will be fabricated at the company’s yard in Egersund, Norway. The contract will have a value of approximately NOK 600 million.The delivery will include both engineering, procurement,

Neste Corporation - Managers' Transactions, Mäki-Kala (disposal)

Neste Corporation, Managers' Transactions, 21 December 2020 at 8.30 a.m. (EET)____________________________________________Person subject to the notification requirementName: Jyrki Mäki-KalaPosition: Chief Financial OfficerIssuer: Neste OyjLEI: 54930096Y1X8GQ66AM14Notification type: INITIAL NOTIFICATIONReference number: 54930096Y1X8GQ66AM14_20201218170119_4____________________________________________Transaction date: 2020-12-18Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009013296Nature of the transaction: DISPOSALTransaction details(1):

Drinking milk while breastfeeding may reduce the child’s food allergy risk

Children of mothers who drink relatively more cow's milk during breastfeeding are at reduced risk of developing food allergies. That is the conclusion of researchers from Chalmers University of Technology, Sweden, in a new study published in the scientific journal Nutrients. The result is based on a survey of more than 500 Swedish women's eating habits and the prevalence of allergies in their children at one year of age. “We have found that mothers of healthy one-year-olds consumed more cow's milk during breastfeeding than mothers of allergic one-year-olds. Though the

Cloudberry Clean Energy AS | Signed SPA to purchase hydropower plants in Norway

Oslo, Norway, 21 December 2020: Cloudberry Clean Energy AS (“Cloudberry” or “the company”) has signed Share Purchase Agreements (SPA) to purchase two hydropower companies in Norway, Selselva Kraft AS and Skåråna Kraft AS, with a total expected annual production of around 34 GWh.Cloudberry, a Nordic renewable energy company, is purchasing the hydropower plants as part of the execution of its growth strategy focused on owning, developing and operating hydro and wind power in Norway and Sweden.  While Selselva Kraft AS is a producing hydropower plant located in Sunnfjord municipality in

Kalmar outsources part of its crane engineering operations in China to Etteplan – Etteplan opens its ninth office in China to Taicang

Etteplan press release December 21, 2020 at 8.00 Etteplan and Kalmar, part of Cargotec, have agreed on the outsourcing of part of Kalmar’s crane engineering operations in China and the transfer of approximately 70 Kalmar’s engineering employees to Etteplan. The deal covers Kalmar’s crane engineering operations in Taicang and Shanghai and will become effective on January 1, 2021. Measured by the number of people, the deal is among the largest outsourcing agreements in Etteplan’s history and also marks the opening of Etteplan’s ninth office in China. With the planned long-term agreement

Fabege first with 100 per cent green financing

Fabege has achieved an important milestone in its sustainability work as all of the company’s loan agreements are now green. Therefore, Fabege is first among the Swedish property companies to exclusively choose green financing.With total borrowing of SEK 26 billion (as of 30 September 2020), Fabege is one of Sweden’s largest borrowers and can thus contribute to a greener financial market by setting a good example. Green financing provides an more robust loan portfolio that handles crises better as well as trusting relationships with creditors and, in addition, lower financing costs. “We

MEDIA STATEMENT BY STENALINE – 20[TH] DECEMBER, 2020 23:00

Important update for passengers intending to travel with Stena Line’s ferry services to the Republic of Ireland and the Netherlands.Due to new measures imposed by the Irish Government and the Government of the Netherlands, there are restrictions on passenger travel into both countries from the UK. Republic of Ireland For at least the next 48 hours from midnight tonight, passenger travel is not permitted on our services from the UK into the Republic of Ireland. Except for essential supply chain workers. This affects our Holyhead to Dublin and our Fishguard to Rosslare services. The

Chairman of the Board Maria Wasing declines re-election at the 2021 Annual General Meeting

Stockholm, Sweden—December 20, 2020— The Chair of the Board of Directors of I.A.R. Systems Group AB, Maria Wasing, has today informed the Nomination Committee that she declines re-election at the 2021 Annual General Meeting. “I want to be able to spend more time on my operational role as COO / vice president at Axiell, as well as developing companies I have active investments in. I am proud to have been a part of IAR Systems during a period where the company broadened its offering from software tools and services for embedded systems to also include advanced security solutions with a

Primary insider disclosure

The following primary insiders (or their related parties as described below) have, as part of the company's incentive program, committed to acquire shares in Ocean Yield ASA (the "Company" or "Ocean Yield"): · Lars Solbakken, CEO of Ocean Yield ASA, has through his wholly owned company Finmarine AS acquired 30,000 shares in Ocean Yield. Upon completion of such acquisition, Lars Solbakken will own, directly or indirectly, 1,700,880 shares in the Company. ·  Marius Magelie, SVP Finance & Investor Relations, has through his wholly owned company MGM Invest AS committed to acquire 7,000

Invitation to Q&A session about Castellum’s increased offer for Entra and the sale of warehouse and logistics properties

Welcome to a digital Q&A session on Monday 21 December at 09:00 am (CET).Due to the publication of the increased share exchange and cash offer to Entra’s shareholders and the sale of a mature stabilized asset portfolio, Castellum invites investors, analysts and journalists to a Q&A session. The session will be hosted by CEO Henrik Saxborn and CFO Ulrika Danielsson. Please register by the following link to participate:https://tv.streamfabriken.com/castellum-press-conference-21-december-2020 

Immunological analysis of Phase IIb trial with Diamyd[®] show differences between genetically defined patient groups

The first immunological results from DIAGNODE-2 show that the the immune response differs significantly between genetically defined patient groups for several immunological parameters following treatment with the diabetes vaccine Diamyd[® ] (GAD-alum). The results are in line with the earlier observed difference in clinical response (announced in September 2020) between individuals positive or negative for HLA type DR3-DQ2. DIAGNODE-2 is a placebo-controlled Phase IIb trial, where Diamyd[®] was injected directly into a lymph node in individuals recently diagnosed with type 1 diabetes.The

Eysturoy tunnel built by NCC opened in Faroe Islands

The Eysturoy tunnel, constructed by NCC for the customer P/E Eystur- og Sandoyartunlar (EST), was formally opened on Saturday. The 11.2 km subsea tunnel represents a significant infrastructure investment, which will reduce travel time to the capital city of Tórshavn from many places in the Faroe Islands. Photo: Estunlar.fo  “NCC congratulates all the people of the Faroe Islands and the company EST on the opening of the tunnel. As the main contractor, we are delighted to deliver, according to schedule, the first of two tunnels that will make life easier for the inhabitants of

Integrum AB granted PMA (premarket approval) by the FDA for the OPRA[™]Implant System

Integrum is both extremely pleased, and proud, to announce the PMA approval issued by the Food and Drug Administration (FDA) in the US for the OPRA[TM] Implant System as a class III medical device.   Integrum is both extremely pleased, and proud, to announce the PMA approval issued by the Food and Drug Administration (FDA) in the US for the OPRA[TM] Implant System as a class III medical device. In a release posted by FDA today, the agency stated: “Today’s approval of the OPRA Implant System expands options for prostheses for individuals who have had above-the-knee

Componenta Corporation resolved on adjustments to share-based incentive plans due to the rights issue and reverse share split

Componenta Corporation, Stock Exchange Release, 18 December at 21:30 The Board of Directors of Componenta Corporation has today, 18 December 2020, resolved on adjustments to the company’s share-based incentive plans. These adjustments are based on the rights issue the final results of which were announced on 9 December 2020, and on the reverse share split executed today, 18 December 2020. Adjustment to the Terms and Conditions of Stock Options 2018 The Board of Directors of Componenta Corporation announced the issue of stock options 2018 on 12 November 2018. Due to the rights issue

There are no items matching the current filter
There are no more items matching the current filter
Back to top